Jenster GW - Search Results

1

The Potential of MicroRNAs as Prostate Cancer Biomarkers.

Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA. Fabris L, et al. Among authors: jenster gw. Eur Urol. 2016 Aug;70(2):312-22. doi: 10.1016/j.eururo.2015.12.054. Epub 2016 Jan 22. Eur Urol. 2016. PMID: 26806656 Free PMC article. Review.

2

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

Marques RB, Erkens-Schulze S, de Ridder CM, Hermans KG, Waltering K, Visakorpi T, Trapman J, Romijn JC, van Weerden WM, Jenster G. Marques RB, et al. Int J Cancer. 2005 Nov 1;117(2):221-9. doi: 10.1002/ijc.21201. Int J Cancer. 2005. PMID: 15900601 Free article.

3

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G. Marques RB, et al. Eur Urol. 2006 Feb;49(2):245-57. doi: 10.1016/j.eururo.2005.12.035. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16413664 Review.

4

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Hendriksen PJ, et al. Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422 Free article.

5

Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.

Jansen FH, Roobol M, Jenster G, Schröder FH, Bangma CH. Jansen FH, et al. Eur Urol. 2009 Mar;55(3):563-74. doi: 10.1016/j.eururo.2008.11.040. Epub 2008 Nov 29. Eur Urol. 2009. PMID: 19058905 Review.

6

ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

Tomlins SA, Bjartell A, Chinnaiyan AM, Jenster G, Nam RK, Rubin MA, Schalken JA. Tomlins SA, et al. Eur Urol. 2009 Aug;56(2):275-86. doi: 10.1016/j.eururo.2009.04.036. Epub 2009 Apr 24. Eur Urol. 2009. PMID: 19409690 Review.

7

Androgen regulation of micro-RNAs in prostate cancer.

Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Waltering KK, et al. Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501

8

Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Marques RB, Dits NF, Erkens-Schulze S, van Weerden WM, Jenster G. Marques RB, et al. PLoS One. 2010 Oct 19;5(10):e13500. doi: 10.1371/journal.pone.0013500. PLoS One. 2010. PMID: 20976069 Free PMC article.

9

Exosomes as biomarker treasure chests for prostate cancer.

Duijvesz D, Luider T, Bangma CH, Jenster G. Duijvesz D, et al. Eur Urol. 2011 May;59(5):823-31. doi: 10.1016/j.eururo.2010.12.031. Epub 2010 Dec 29. Eur Urol. 2011. PMID: 21196075 Review.

10

The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.

Porkka KP, Ogg EL, Saramäki OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi OP, Jenster G, Visakorpi T. Porkka KP, et al. Genes Chromosomes Cancer. 2011 Jul;50(7):499-509. doi: 10.1002/gcc.20873. Epub 2011 Mar 31. Genes Chromosomes Cancer. 2011. PMID: 21472816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page